The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. (Q43262077)
Jump to navigation
Jump to search
scientific article published on 20 September 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. |
scientific article published on 20 September 2004 |
Statements
The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin (English)
Sonia A Tucci
Elizabeth K Rogers
20 September 2004
1 reference
1 reference